SEC Form 4 · accession 0001571049-17-002511

PHIBRO ANIMAL HEALTH CORP · PAHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Sr VP, Human Resources

Period of report

Feb 27, 2017

Accepted (ET)

Mar 16, 2017 · 7:51 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001069899

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock^F1,F6	Feb 27, 2017	M	3,100	$11.83	A	3,100	D
Class A Common Stock^F2,F6	Feb 27, 2017	M	1,900	$11.83	A	1,900	D
Class A Common Stock^F6,F4	Feb 27, 2017	S	5,000	$28.30	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option to purchase Class A Common Stock^F5,F6	$11.83	Feb 27, 2017	M	3,100	D	Mar 1, 2012	Feb 28, 2019	Class A Common Stock	3,100	0	D
Option to purchase Class A Common Stock^F6	$11.83	Feb 27, 2017	M	1,900	D	Mar 1, 2013	Feb 28, 2019	Class A Common Stock	1,900	9,150	D

F1Reflects conversions of options with an exercisable date of March 1, 2012.
F2Reflects conversions of options with an exercisable date of March 1, 2013.
F3The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.95 to $28.75, inclusive.
F5The Date Exercisable for the securities included on this line was incorrectly reported in the Form 4 for Mr. Welch filed on February 16, 2017. The information in this line reflects the correct Date Exercisable for the Options to purchase Class A Common Stock.
F6Report is being submitted late due to a technical error.